Preparation via coligand exchange and characterization of [^99mTc‐EDDA‐HYNIC‐D‐Phe¹,Tyr³]Octreotide (^99mTc–EDDA/HYNIC–TOC)

This publication has 11 references indexed in Scilit:

• Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Radio-LC-MS for the Characterization of ^99mTc-Labeled Bioconjugates
  Bioconjugate Chemistry, 1999
• The integrity of the disulfide bond in a cyclic somatostatin analog during 99mtc complexation reactions
  Nuclear Medicine and Biology, 1999
• Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence
  European Journal of Nuclear Medicine and Molecular Imaging, 1999
• Preparation, ^99mTc-Labeling, and in Vitro Characterization of HYNIC and N₃S Modified RC-160 and [Tyr³]Octreotide
  Bioconjugate Chemistry, 1999
• A Novel Ternary Ligand System for ^99mTc-Labeling of Hydrazino Nicotinamide-Modified Biologically Active Molecules Using Imine-N-Containing Heterocycles as Coligands
  Bioconjugate Chemistry, 1998
• New and Versatile Ternary Ligand System for Technetium Radiopharmaceuticals: Water Soluble Phosphines and Tricine as Coligands in Labeling a Hydrazinonicotinamide-Modified Cyclic Glycoprotein IIb/IIIa Receptor Antagonist with ^99mTc
  Bioconjugate Chemistry, 1997
• Somatostatinrezeptor- szintigraphie Methodik, Indikationen, Ergebnisse
  Der Radiologe, 1996
• [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation
  Life Sciences, 1991